Antidiabetic drugs influence molecular mechanisms in prostate cancer by Andreas Pircher, Martin Zieher, Andrea Eigentler, Renate Pichler, Georg Schäfer, Josef Fritz, Martin Puhr, Eberhard Steiner, Wolfgang Horninger, Helmut Klocker, Isabel Heidegger

Get full text

The impact of androgen-induced translation in modulating androgen receptor activity by Justus S. Israel, Laura-Maria Marcelin, Sherif Mehralivand, Jana Scholze, Jörg Hofmann, Matthias B. Stope, Martin Puhr, Christian Thomas, Holger H. H. Erb

Get full text

New advances of the androgen receptor in prostate cancer: report from the 1st International Androgen Receptor Symposium by Sherif Mehralivand, Christian Thomas, Martin Puhr, Frank Claessens, Arjanneke F. van de Merbel, Anna Dubrovska, Guido Jenster, Christof Bernemann, Ulrich Sommer, Holger H. H. Erb

Get full text

The CHK1 inhibitor MU380 significantly increases the sensitivity of human docetaxel‐resistant prostate cancer cells to gemcitabine through the induction of mitotic catastrophe by Stanislav Drápela, Prashant Khirsariya, Wytske M. vanWeerden, Radek Fedr, Tereza Suchánková, Diana Búzová, Jan Červený, Aleš Hampl, Martin Puhr, William R. Watson, Zoran Culig, Lumír Krejčí, Kamil Paruch, Karel Souček

Get full text

Therapy-Induced Stromal Senescence Promoting Aggressiveness of Prostate and Ovarian Cancer by Elisa Pardella, Erica Pranzini, Ilaria Nesi, Matteo Parri, Pietro Spatafora, Eugenio Torre, Angela Muccilli, Francesca Castiglione, Massimiliano Fambrini, Flavia Sorbi, Paolo Cirri, Anna Caselli, Martin Puhr, Helmut Klocker, Sergio Serni, Giovanni Raugei, Francesca Magherini, Maria Letizia Taddei

Get full text

Emerging frontiers in androgen receptor research for prostate Cancer: insights from the 2nd international androgen receptor Symposium by Justus Simon Israel, Laura-Maria Marcelin, Christian Thomas, Eva Szczyrbová, Susanne Fuessel, Martin Puhr, Johannes Linxweiler, Shivani Yalala, Wilbert T. Zwart, Aria Baniahmad, Jasper van Goubergen, Harri M. Itkonen, Adam Sharp, Edward O’Neill, Marc Pretze, Matthias Miederer, Holger H.H. Erb

Get full text

ZEB1‐associated drug resistance in cancer cells is reversed by the class I HDAC inhibitor mocetinostat by Simone Meidhof, Simone Brabletz, Waltraut Lehmann, Bogdan‐Tiberius Preca, Kerstin Mock, Manuel Ruh, Julia Schüler, Maria Berthold, Anika Weber, Ulrike Burk, Michael Lübbert, Martin Puhr, Zoran Culig, Ulrich Wellner, Tobias Keck, Peter Bronsert, Simon Küsters, Ulrich T Hopt, Marc P Stemmler, Thomas Brabletz

Get full text